CALCA and irritable bowel syndrome: CGRP levels were particularly elevated in many clinical CPP subtypes and animal models (such as primary trigeminal neuralgia [73, 74], migraine [56], IBS [75] and fibromyalgia syndrome [76, 77], and inhibiting or blocking CGRP signaling pathway is an effective strategy to treat migraine [78, 79].